Severe secondary hyperparathyroidism: Intravenous calcitriol treatment or parathyroidectomy?

被引：0

作者：

Diezhandino, MG

PerezGarcia, R

LopezGomez, JM

Jofre, R

Valderrabano, F

机构：

来源：

CLINICAL NEPHROLOGY | 1996年 / 45卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：69 / 70

页数：2

共 10 条

[1] INTRAVENOUS CALCITRIOL IN THE TREATMENT OF REFRACTORY OSTEITIS FIBROSA OF CHRONIC RENAL-FAILURE [J].

ANDRESS, DL ;

NORRIS, KC ;

COBURN, JW ;

SLATOPOLSKY, EA ;

SHERRARD, DJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (05) :274-279

[2] DECREASED 1,25-DIHYDROXYVITAMIN-D(3) RECEPTOR DENSITY IS ASSOCIATED WITH A MORE SEVERE FORM OF PARATHYROID HYPERPLASIA IN CHRONIC UREMIC PATIENTS [J].

FUKUDA, N ;

TANAKA, H ;

TOMINAGA, Y ;

FUKAGAWA, M ;

KUROKAWA, K ;

SEINO, Y .

JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (03) :1436-1443

[3] REDUCED BINDING OF [H-3] 1,25-DIHYDROXYVITAMIN-D3 IN THE PARATHYROID-GLANDS OF PATIENTS WITH RENAL-FAILURE [J].

KORKOR, AB .

NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (25) :1573-1577

[4]

LIACH F, 1993, NEFROLOGIA S3, V13, P39

[5]

MALBERTI F, 1992, NEPHROL DIAL TRANSPL, V7, P822

[6] DIMINISHED PARATHYROID 1,25(OH)2D3 RECEPTORS IN EXPERIMENTAL UREMIA [J].

MERKE, J ;

HUGEL, U ;

ZLOTKOWSKI, A ;

SZABO, A ;

BOMMER, J ;

MALL, G ;

RITZ, E .

KIDNEY INTERNATIONAL, 1987, 32 (03) :350-353

[7]

NORRIS KC, 1986, J BONE MINER RES S1, V1, P374

[8] MARKED SUPPRESSION OF SECONDARY HYPERPARATHYROIDISM BY INTRAVENOUS ADMINISTRATION OF 1,25-DIHYDROXYCHOLECALCIFEROL IN UREMIC PATIENTS [J].

SLATOPOLSKY, E ;

WEERTS, C ;

THIELAN, J ;

HORST, R ;

HARTER, H ;

MARTIN, KJ .

JOURNAL OF CLINICAL INVESTIGATION, 1984, 74 (06) :2136-2143

[9]

SLATOPOLSKY E, 1990, KIDNEY INT S29, V38, P541

[10] AP ENDONUCLEASES AND DNA GLYCOSYLASES THAT RECOGNIZE OXIDATIVE DNA DAMAGE [J].

WALLACE, SS .

ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 1988, 12 (04) :431-477

← 1 →